Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Bone and joint problems news

Show

From To
Limited evidence that vitamin D supplements of any benefit for patients with HIV

There is only scant evidence that vitamin D supplementation is of benefit for patients with HIV, according to UK investigators writing in the January 28th  edition of

Published
10 January 2012
By
Michael Carter
HIV Worsens Bone Loss After Menopause

Compared to a control group, postmenopausal women with HIV infection had higher rates of bone loss and could well have a higher risk for fracture as they age, according to the researchers who conducted the study.

Published
03 January 2012
From
Medscape (requires free registration)
Raltegravir kinder to bones and body fat than boosted protease inhibitors in Spanish trial

Raltegravir (Isentress)-based treatment appears to have a more favourable impact on fat accumulation and bone metabolism compared to therapy based on a ritonavir-boosted protease inhibitor, according to Spanish

Published
28 November 2011
By
Michael Carter
Patients on HIV therapy have an increased risk of stress and fragility fractures; no link to specific drug

Patients taking antiretroviral therapy have an increased risk of fractures typically associated with low bone mineral density, Danish investigators report in the online edition of AIDS. However, the

Published
28 November 2011
By
Michael Carter
Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks

A two-drug antiretroviral combination comprising raltegravir and ritonavir-boosted lopinavir has only a modest impact on bone mineral density, a study presented to the International AIDS Society conference (IAS

Published
19 July 2011
By
Michael Carter
Doubt remains if HIV therapy increases the risk of fragility fractures

The relationship between HIV therapy and fracture risk is far from straightforward, US research presented to the International AIDS Society conference (IAS 2011) in Rome suggests. An analysis

Published
18 July 2011
By
Michael Carter
Marker of cardiovascular disease also associated with bone problems in patients with HIV

An important marker of sub-clinical cardiovascular risk is associated with reduced bone mineral density in the hips of HIV-positive patients, according to Italian research presented to the Sixth

Published
18 July 2011
By
Michael Carter
Tenofovir and bone loss: treatment causes early changes in thyroid hormone levels

Treatment with tenofovir increases levels of a hormone associated with calcium metabolism, Spanish investigators report in the online edition of AIDS Research and Human Retroviruses. This finding is

Published
19 June 2011
By
Michael Carter
Panel Issues New Guidelines on Ideal Vitamin D Levels

An expert panel has issued new recommendations suggesting that people with HIV might require two to three times the level of vitamin D as their HIV-negative peers.

Published
10 June 2011
From
AIDSMeds.com
Low CD4 increases risk of fragility fractures for patients with HIV

A low CD4 cell count is associated with an increased risk of fragility fractures in patients with HIV, an Australian study published in the online edition of

Published
04 May 2011
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.